EFFECTIVENESS OF LIFESTYLE MODIFICATION VS. PHARMACOLOGIC TREATMENT IN STAGE 1 HYPERTENSION
Bibliographic record
Abstract
Background: Stage 1 hypertension is a prevalent cardiovascular risk factor, affecting a significant proportion of the adult population worldwide. While both lifestyle modification and pharmacologic therapy are endorsed in clinical guidelines, the optimal approach for initial management in patients without comorbidities remains unclear. Existing literature often evaluates these interventions separately, lacking direct comparisons specific to early-stage hypertension. Objective: This systematic review aims to evaluate and compare the effectiveness of lifestyle modification versus pharmacologic treatment in reducing blood pressure and preventing cardiovascular events in adults with stage 1 hypertension. Methods: A systematic review was conducted following PRISMA guidelines. Four databases—PubMed, Scopus, Web of Science, and Cochrane Library—were searched for articles published between January 2019 and April 2024. Eligible studies included randomized controlled trials and prospective cohort studies comparing lifestyle interventions (e.g., diet, exercise, weight loss) with antihypertensive medications in adults with stage 1 hypertension. Data extraction and risk of bias assessments were performed independently by two reviewers using standardized tools (Cochrane RoB 2 and Newcastle-Ottawa Scale). Results: Eight studies involving 3,846 participants were included. Pharmacologic treatments resulted in faster and slightly greater reductions in systolic and diastolic blood pressure (mean SBP reduction: 9–14 mmHg; p < 0.001), while lifestyle interventions produced sustained, clinically meaningful reductions (mean SBP reduction: 6–11 mmHg; p < 0.05). Four studies reported reduced cardiovascular event rates in lifestyle groups over extended follow-up periods. Risk of bias was generally low to moderate across studies. Conclusion: Both lifestyle modification and pharmacologic therapy are effective in managing stage 1 hypertension. Lifestyle interventions offer additional long-term cardiovascular benefits and may serve as a preferred initial strategy in select patients. Further large-scale, long-duration comparative trials are needed to reinforce these findings.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.010 | 0.035 |
| Meta-epidemiology (narrow) | 0.001 | 0.001 |
| Meta-epidemiology (broad) | 0.008 | 0.012 |
| Bibliometrics | 0.003 | 0.002 |
| Science and technology studies | 0.000 | 0.001 |
| Scholarly communication | 0.002 | 0.001 |
| Open science | 0.001 | 0.001 |
| Research integrity | 0.002 | 0.001 |
| Insufficient payload (model declined to judge) | 0.003 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".